Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02032823
Brief Title: Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA)

First Submitted : January 3, 2014
First Submitted that Met QC Criteria : January 9, 2014
First Posted : January 10, 2014 (Estimate)

Certification/Extension First Submitted : March 5, 2021
Certification/Extension First Submitted that Met QC Criteria : March 5, 2021
Certification/Extension First Posted : March 9, 2021

Last Update Submitted that Met QC Criteria : March 5, 2021
Last Update Posted : March 9, 2021